StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Vertex Pharmaceuticals Incorporated

Enter Symbol or Keywords

Cash Flow from Operations for Vertex Pharmaceuticals Reaches Thirteen Year Low

Stock Quote: (NasdaqNM:VRTX)

11/17/2009

38.07

+0.65

+1.74%

877,730

Cash Flow from Operations for Vertex Pharmaceuticals Reaches Thirteen Year Low

Last

Price Change

% Chg

Volume

New York, NY, November 17, 2009-CFFO-NEWS reports that negative Cash Flow from Operations (CFFO) for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for its twelve months ended September 30, 2009 wa ... read full story

Website Address:	www.vpharm.com
Industry:	Vaccine, Antibodies, Immunities

Most Recent STN Exclusives

02/09/2010

Cash Flow from Operations Improves 82% for News Corp.

02/09/2010

Revenue for Coach Increases by 3.25% even though Revenue for Apparel Industry Decreases by -22.4% over Latest 12 Months

02/09/2010

Free Cash Flow for News Corp. Reaches Two Year High

02/09/2010

Cash Flow from Operations Turns Positive for Siemens' First Quarter

02/09/2010

StockDiagnostics.com Has Issued a Cashless Earnings Warning For Energy XXI

02/08/2010

Second Quarter EBITDA Turns Positive for Harris

02/08/2010

Twelve Year High in EBITDA for Amazon.com

02/08/2010

Cash Flow from Operations for McCormick Reaches Fifteen Year High

02/08/2010

EBITDA for BMC Software Reaches Thirteen Year High

02/08/2010

EBITDA for CA Reaches Nine Year High

Interactive Chart: VRTX

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: VRTX

11/19/2009

EBITDA for Vertex Pharmaceuticals Reaches Twelve Year Low

11/17/2009

Vertex Pharmaceuticals bucks its Industry’s Revenue Increase of 7.82% with a Decline of -47.95%

11/17/2009

StockDiagnostics.com Reiterates Vertex Pharmaceuticals' OPS Ranking of "8"

... more VRTX exclusives

Other News Sources: VRTX

02/04/2010

VRTX: Q4 Adj EPS (66c) vs (85c) Beats (85c) Est

02/04/2010

Vertex Pharmaceuticals Reports 2009 Financial Results and Highlights Recent Progress in Hepatitis C and Cystic Fibrosis Development Programs

02/03/2010

Vertex Announces Results from Phase 2a Trial of VX-809 Targeting the Defective Protein Responsible for Cystic Fibrosis

... more VRTX news from other sources

Daily Market Updates

02/09/2010

Rally Continues at Midday on Reports of EU Support for Greece

The indices continue to rally at midday, and stocks have seen their best one-day performance since July 2009 during this session after an easing of fears regarding sovereign debt issues in Europe. An earlier report today had indictated that the Euro ... read full story